Suneva® Medical, Inc., a privately held aesthetics company, is pleased to announce the recent closing of a $15 million capital raise that will allow the company to reduce existing debt and support the growth and expansion of Suneva Medical as the leader in regenerative aesthetics.

Suneva Medical, Inc. headquartered in San Diego, CA is a leader in regenerative aesthetics. It is focused on developing, manufacturing and commercializing branded products for providers and their patients. Suneva Medical offers a portfolio of best-in-class products that include Bellafill®, the only FDA approved 5-year filler, Silhouette Instalift®, the first resorbable suture FDA cleared for cosmetic facial procedures, PuregraftTM, a unique fat grafting system, DermaposeTM, an all-in-one system to harvest, wash and inject sized fat and AmplifineTM, an innovative high density platelet rich plasma (PRP) gel tube. For more information, visit www.sunevamedical.com.

Suneva Medical Completes $15 Million Capital Raise With Avenue Venture Opportunities Fund, L.P.

Suneva Medical Completes $15 Million Capital Raise With Avenue Venture Opportunities Fund, L.P.

Company Info